InvestorsHub Logo
Followers 20
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: pottsvision post# 1604

Monday, 02/17/2020 5:30:58 PM

Monday, February 17, 2020 5:30:58 PM

Post# of 1722

pottsvision

Excellent breakdown. I`am semi experienced in the cancer biotech area and now there are literally 100 of company's chasing cancer in one form or another and TEVO has some good science and trials going for them. It has also attracted the shorts/day traders and bots. This stock should be easily trading at $3.00+. Give this more time to blossom and keep a trading position to ease the pain as it`s still too early call on their lead product, PCM-075, the Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. GL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News